Procept Biorobotics Corp (PRCT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) has a cash flow conversion efficiency ratio of -0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.63 Million) by net assets ($380.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PRCT market cap overview for the company's overall valuation and market capitalisation.
Procept Biorobotics Corp - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Procept Biorobotics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Procept Biorobotics Corp ranked by their cash flow conversion efficiency. See debt repayment capacity of Procept Biorobotics Corp to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Sanwei Rubber Item Co
SHG:603033
|
0.002x |
|
Shenzhen Click Technology Co Ltd
SHE:002782
|
0.039x |
|
Jiangyin Hengrun Heavy
SHG:603985
|
0.009x |
|
Sixt SE
XETRA:SIX3
|
0.081x |
|
Guangzhou Restaurants Group Co
SHG:603043
|
0.243x |
|
Elbit Systems Ltd
TA:ESLT
|
0.081x |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
N/A |
|
Gielda Papierow Wartosciowych w Warszawie SA
WAR:GPW
|
0.020x |
Annual Cash Flow Conversion Efficiency for Procept Biorobotics Corp (2019–2024)
The table below shows the annual cash flow conversion efficiency of Procept Biorobotics Corp from 2019 to 2024. View Procept Biorobotics Corp stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $402.22 Million | $-99.21 Million | -0.247x | +35.88% |
| 2023-12-31 | $280.75 Million | $-108.00 Million | -0.385x | +5.69% |
| 2022-12-31 | $197.07 Million | $-80.38 Million | -0.408x | -90.01% |
| 2021-12-31 | $267.09 Million | $-57.33 Million | -0.215x | +72.93% |
| 2020-12-31 | $60.96 Million | $-48.34 Million | -0.793x | +47.10% |
| 2019-12-31 | $29.23 Million | $-43.82 Million | -1.499x | -- |
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more